Wave Life Sciences WVE Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $544.59M+124% | $602.07M+99.3% | $196.22M-36.9% | $208.48M+35.4% | $243.08M+34.4% | ||
| $3.82M+1.1% | $3.81M+1.2% | $3.8M+1.3% | $3.78M+1.4% | $3.77M+1.5% | ||
| $0+100% | $1.28M-10.3% | $10M— | $1.62M+25.3% | -$1.42M— | ||
| $561.27M+118% | $614.81M+91.9% | $215.49M-33.6% | $223.56M+29.9% | $257.98M+31.1% | ||
| $7.08M-26.0% | $7.41M-26.9% | $8.2M-25.0% | $9.04M-23.3% | $9.57M-23.0% | ||
| $10.99M-33.7% | $12.46M-30.3% | $13.88M-27.4% | $15.25M-25.0% | $16.58M-22.9% | ||
| $386K-13.8% | $16K-70.9% | $22K-88.8% | $728K-19.1% | $448K-48.4% | ||
| $22.27M-26.7% | $23.69M-25.5% | $25.89M-23.8% | $28.8M-21.6% | $30.37M-21.1% | ||
| $583.54M+102% | $638.5M+81.3% | $241.38M-32.7% | $252.36M+20.8% | $288.34M+22.6% | ||
| $19.06M+32.8% | $15.7M-3.5% | $14.49M+13.4% | $14.66M-19.2% | $14.36M+22.4% | ||
| $13.04M+66.9% | $26.56M+26.0% | $16.49M+12.6% | $13.03M+22.0% | $7.81M+18.0% | ||
| $9.4M-83.6% | $44.44M-32.6% | $46.53M-65.8% | $51.58M-62.4% | $57.31M-59.2% | ||
| $8.33M+5.6% | $8.36M+9.5% | $8.39M+13.5% | $8.14M+13.6% | $7.88M+13.7% | ||
| $14.6M+161% | $7.8M+27.9% | $11.68M-36.8% | $4.23M-55.8% | $5.58M-55.5% | ||
| $49.83M-43.0% | $95.07M-14.3% | $85.9M-49.7% | $87.41M-49.5% | $87.37M-47.3% | ||
| $7.39M-53.0% | $9.41M-47.1% | $11.38M-42.5% | $13.58M-37.5% | $15.72M-33.4% | ||
| $21.98M+3.2% | $17.2M-27.9% | $23.06M-39.7% | $17.81M-43.1% | $21.3M-41.1% | ||
| $71.81M-33.9% | $112.27M-16.7% | $108.96M-47.9% | $105.22M-48.5% | $108.67M-46.2% | ||
| $1.63B+37.9% | $1.62B+37.6% | $1.22B+7.4% | $1.19B+25.3% | $1.18B+24.2% | ||
| $237.43M+47.1% | $228.37M+46.0% | $174.08M+13.6% | $167.6M+23.6% | $161.41M+22.2% | ||
| -$1.35B-15.7% | -$1.33B-18.2% | -$1.27B-10.6% | -$1.22B-11.9% | -$1.17B-10.6% | ||
| -$254K-24.5% | -$250K+4.6% | -$190K-19.5% | -$161K+42.3% | -$204K-3.0% | ||
| $511.73M+198% | $518.36M+147% | $124.55M-12.1% | $139.27M+4,105% | $171.8M+577% | ||
| $583.54M+102% | $638.5M+81.3% | $241.38M-32.7% | $252.36M+20.8% | $288.34M+22.6% | ||
| $3.46M-49.5% | $3.08M-58.2% | $2.62M-12.6% | $6.76M+44.4% | $6.84M+45.3% | ||
| $386K-13.8% | $16K-70.9% | $22K— | $728K— | $448K— | ||
| $10.99M-33.7% | $12.46M-30.3% | $13.88M-27.4% | $15.25M-25.0% | $16.58M-22.9% | ||
| $10.99M-33.7% | $12.46M-30.3% | $13.88M-27.4% | $15.25M-25.0% | $16.58M-22.9% | ||
| $386K-13.8% | $16K-70.9% | $22K— | $728K— | $448K— | ||
| $10.99M-33.7% | $12.46M-30.3% | $13.88M-27.4% | $15.25M-25.0% | $16.58M-22.9% | ||
| $386K-13.8% | $16K-70.9% | $22K— | $728K— | $448K— | ||
| $14.6M+161% | $7.8M+27.9% | $11.68M-36.8% | $4.23M-55.8% | $5.58M-55.5% | ||
| $14.6M+161% | $7.8M+27.9% | $11.68M-36.8% | $4.23M-55.8% | $5.58M-55.5% | ||
| $13.04M+66.9% | $26.56M+26.0% | $16.49M+12.6% | $13.03M+22.0% | $7.81M+18.0% | ||
| $14.6M+161% | $7.8M+27.9% | $11.68M-36.8% | $4.23M-55.8% | $5.58M-55.5% | ||
| $15.72M-33.4% | $17.77M-30.1% | $19.77M-27.2% | $21.71M-24.8% | $23.6M-22.7% | ||
| $1.63B+37.9% | $1.62B+37.6% | $1.22B+7.4% | $1.19B+25.3% | $1.18B+24.2% | ||
| $13.23M+64.0% | $8.4M-12.0% | $6.65M-37.1% | $6.7M-44.8% | $8.06M-27.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Wave Life Sciences's total assets?
- Wave Life Sciences (WVE) holds $583.5M in total assets, up 102.4% year over year.
- How much debt does Wave Life Sciences have?
- Wave Life Sciences carries $15.7M in total debt against $511.7M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Wave Life Sciences have?
- Wave Life Sciences holds $544.6M in cash and equivalents.
- Can Wave Life Sciences cover its short-term obligations?
- Its current ratio is 11.26 — current assets exceed current liabilities.
- Where does Wave Life Sciences's balance sheet data come from?
- Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
